Literature DB >> 29022413

Moderate O3/O2 therapy enhances enzymatic and non-enzymatic antioxidant in brain and cochlear that protects noise-induced hearing loss.

Parvaneh Nasezadeh1, Farshad Shahi2, Mohammadjavad Fridoni3, Enayatollah Seydi4, Morteza Izadi5, Ahmad Salimi6.   

Abstract

Mitochondrial damage and oxidative stress are known to contribute to the pathogenesis of noise-induced hearing loss (NIHL). In this study, we examined the protective effect of O2/O3 mixture (ozone/oxygen) therapy against mitochondrial induced damage and oxidative stress by noise exposure in rat brain and cochlear. For this purpose, rats were divided into four groups: 1 - control group; 2 - noise-exposed group (100 dB); 3 - noise + O2/O3, and 4 - O2/O3 (30 µg/ml). After 14 d, animals were anesthetised. Rat brain and cochlear tissue were removed for evaluation of the histopathological damages, oxidative stress, and mitochondrial dysfunction in both tissues. Our findings indicated that noise caused pathological damage, oxidative stress, and mitochondrial dysfunction in rat brain and cochlear. Also, daily administration of an O2/O3 therapy (30 µg/ml intravenous) efficiently increased enzymatic and non-enzymatic antioxidant in brain and cochlear that this action led to inhibition of pathological damages, oxidative stress, reactive oxygen species formation, mitochondrial membrane potential (MMP) collapse, mitochondrial swelling, and cytochrome c release resulting from noise. These findings suggest that the moderate O2/O3 therapy enhances the capacity of enzymatic and non-enzymatic antioxidant in brain and cochlear that protects against NIHL.

Entities:  

Keywords:  Ozone/oxygen therapy; hearing loss; mitochondria; noise; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 29022413     DOI: 10.1080/10715762.2017.1381695

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  4 in total

1.  The effectiveness of berberine on noise-induced hearing loss: a rat model.

Authors:  Korhan Kilic; Muhammed Sedat Sakat; Abdulkadir Sahin; Serkan Yildirim; Muhammet Bahaeddin Dortbudak
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

Review 2.  Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.

Authors:  Morteza Izadi; Luca Cegolon; Mohammad Javanbakht; Ali Sarafzadeh; Hassan Abolghasemi; Gholamhossein Alishiri; Shi Zhao; Behzad Einollahi; Mandana Kashaki; Nematollah Jonaidi-Jafari; Mosa Asadi; Ramezan Jafari; Saeid Fathi; Hassan Nikoueinejad; Mehrdad Ebrahimi; Sina Imanizadeh; Amir Hosein Ghazale
Journal:  Int Immunopharmacol       Date:  2020-12-21       Impact factor: 5.714

3.  The biological activity of medical ozone in the hormetic range and the role of full expertise professionals.

Authors:  Marianno Franzini; Luigi Valdenassi; Sergio Pandolfi; Umberto Tirelli; Giovanni Ricevuti; Vincenzo Simonetti; Massimiliano Berretta; Francesco Vaiano; Salvatore Chirumbolo
Journal:  Front Public Health       Date:  2022-09-16

4.  Correlation of SOD and MDA Expression in the Organ of Corti and Changes in the Function of Outer Hair Cells Measured by DPOAE Examination in Noise-Exposed Rat Cochlea.

Authors:  Reastuty Reastuty; Tengku Siti Hajar Haryuna
Journal:  Rep Biochem Mol Biol       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.